397 related articles for article (PubMed ID: 36980276)
1. Shifting the Cancer Screening Paradigm: The Rising Potential of Blood-Based Multi-Cancer Early Detection Tests.
Brito-Rocha T; Constâncio V; Henrique R; Jerónimo C
Cells; 2023 Mar; 12(6):. PubMed ID: 36980276
[TBL] [Abstract][Full Text] [Related]
2. Attitudes to multi-cancer early detection (MCED) blood tests for population-based screening: A qualitative study in Great Britain.
Schmeising-Barnes N; Waller J; Marlow LAV
Soc Sci Med; 2024 Apr; 347():116762. PubMed ID: 38520825
[TBL] [Abstract][Full Text] [Related]
3. The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA.
Tafazzoli A; Ramsey SD; Shaul A; Chavan A; Ye W; Kansal AR; Ofman J; Fendrick AM
Pharmacoeconomics; 2022 Nov; 40(11):1107-1117. PubMed ID: 36038710
[TBL] [Abstract][Full Text] [Related]
4. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.
Klein EA; Richards D; Cohn A; Tummala M; Lapham R; Cosgrove D; Chung G; Clement J; Gao J; Hunkapiller N; Jamshidi A; Kurtzman KN; Seiden MV; Swanton C; Liu MC
Ann Oncol; 2021 Sep; 32(9):1167-1177. PubMed ID: 34176681
[TBL] [Abstract][Full Text] [Related]
5. Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests.
Gelhorn H; Ross MM; Kansal AR; Fung ET; Seiden MV; Krucien N; Chung KC
Patient; 2023 Jan; 16(1):43-56. PubMed ID: 35844011
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA.
Chen X; Dong Z; Hubbell E; Kurtzman KN; Oxnard GR; Venn O; Melton C; Clarke CA; Shaknovich R; Ma T; Meixiong G; Seiden MV; Klein EA; Fung ET; Liu MC
Clin Cancer Res; 2021 Aug; 27(15):4221-4229. PubMed ID: 34088722
[TBL] [Abstract][Full Text] [Related]
7. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK.
Hackshaw A; Cohen SS; Reichert H; Kansal AR; Chung KC; Ofman JJ
Br J Cancer; 2021 Nov; 125(10):1432-1442. PubMed ID: 34426664
[TBL] [Abstract][Full Text] [Related]
8. Circulating cell-free DNA-based multi-cancer early detection.
Zhang K; Fu R; Liu R; Su Z
Trends Cancer; 2024 Feb; 10(2):161-174. PubMed ID: 37709615
[TBL] [Abstract][Full Text] [Related]
9. Integrating Artificial Intelligence for Advancing Multiple-Cancer Early Detection via Serum Biomarkers: A Narrative Review.
Wang HY; Lin WY; Zhou C; Yang ZA; Kalpana S; Lebowitz MS
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473224
[TBL] [Abstract][Full Text] [Related]
10. Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling.
Lange JM; Gogebakan KC; Gulati R; Etzioni R
Cancer Epidemiol Biomarkers Prev; 2024 Jun; 33(6):830-837. PubMed ID: 38506751
[TBL] [Abstract][Full Text] [Related]
11. New genomic technologies for multi-cancer early detection: Rethinking the scope of cancer screening.
Hackshaw A; Clarke CA; Hartman AR
Cancer Cell; 2022 Feb; 40(2):109-113. PubMed ID: 35120599
[TBL] [Abstract][Full Text] [Related]
12. Multi-Cancer Early Detection Tests: Current Progress and Future Perspectives.
Loomans-Kropp HA; Umar A; Minasian LM; Pinsky PF
Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):512-514. PubMed ID: 35253043
[TBL] [Abstract][Full Text] [Related]
13. The clinical and economic benefits associated with novel multi-cancer early detection tests: conference highlights from the 2022 ISPOR Annual Meeting.
Nabavizadeh N
Am J Manag Care; 2022 Aug; 28(7 Suppl):S123-S132. PubMed ID: 36067342
[TBL] [Abstract][Full Text] [Related]
14. [Liquid biopsy: a possible approach for cancer screening].
Thierry AR; Tanos R
Med Sci (Paris); 2018 Oct; 34(10):824-832. PubMed ID: 30451677
[TBL] [Abstract][Full Text] [Related]
15. Circulating Tumor DNA Allele Fraction: A Candidate Biological Signal for Multicancer Early Detection Tests to Assess the Clinical Significance of Cancers.
Bredno J; Venn O; Chen X; Freese P; Ofman JJ
Am J Pathol; 2022 Oct; 192(10):1368-1378. PubMed ID: 35948080
[TBL] [Abstract][Full Text] [Related]
16. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
17. Helping patients understand multi-cancer early detection tests: a scoping review.
Greene MP; Vassy JL
Per Med; 2024; 21(2):131-137. PubMed ID: 38269535
[TBL] [Abstract][Full Text] [Related]
18. Stage Shift as an Endpoint in Cancer Screening Trials: Implications for Evaluating Multicancer Early Detection Tests.
Owens L; Gulati R; Etzioni R
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1298-1304. PubMed ID: 35477176
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsies: the future of cancer early detection.
Connal S; Cameron JM; Sala A; Brennan PM; Palmer DS; Palmer JD; Perlow H; Baker MJ
J Transl Med; 2023 Feb; 21(1):118. PubMed ID: 36774504
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive detection of any-stage cancer using free glycosaminoglycans.
Bratulic S; Limeta A; Dabestani S; Birgisson H; Enblad G; Stålberg K; Hesselager G; Häggman M; Höglund M; Simonson OE; Stålberg P; Lindman H; Bång-Rudenstam A; Ekstrand M; Kumar G; Cavarretta I; Alfano M; Pellegrino F; Mandel-Clausen T; Salanti A; Maccari F; Galeotti F; Volpi N; Daugaard M; Belting M; Lundstam S; Stierner U; Nyman J; Bergman B; Edqvist PH; Levin M; Salonia A; Kjölhede H; Jonasch E; Nielsen J; Gatto F
Proc Natl Acad Sci U S A; 2022 Dec; 119(50):e2115328119. PubMed ID: 36469776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
